RetinAI had the pleasure to present in the 124e Congrès International de la Société Française d'Ophthalmologie in the session: 'L'impact de l'intelligence artificielle dans la santé visuelle', organised by Optic 2000 in Paris! Wonderful day presenting how AI and machine learning are changing the current paradigm of screening and monitoring of eye diseases.
RetinAI is getting ready for the American Research in Vision and Ophthalmology #ARVO2018 in Hawaii! Come to our booth 1039 if you want to learn about how #AI is changing the world of ophthalmic care!
RetinAI has been selected as one of the TOP50 Swiss startups in which to invest by the Bilan Magazine. The committee of experts evaluated the progress and projection of hundreds of startups from the Swiss ecosystem and selected the 50 most promising technologies for 2018! Congratulations to the team for this great success.
Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence.